Glenmark concludes study on COVID drug Favipiravir

Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diarrhoea, vomiting etc were found to be mild in nature. The time for fever resolution was 4 days, while the time for the clinical cure was 7 days, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news